Search
for
Sort by
Research 91–120 of 188
- Epidemiological study of prostate cancer (EPICAP): a population-based case–control study in France
- Effective treatment of intractable diseases using nanoparticles to interfere with vascular supply and angiogenic process
- Recent Advances in the Use of Cubosomes as Drug Carriers with Special Emphasis on Topical Applications
- Formulation and optimization of folate-bovine serum albumin-coated ethoniosomes of pterostilbene as a targeted drug delivery system for lung cancer: In vitro and in vivo demonstrations
- Thiazole: A Versatile Standalone Moiety Contributing to the Development of Various Drugs and Biologically Active Agents
- The prostaglandin synthases, COX-2 and L-PGDS, mediate prostate hyperplasia induced by low-dose bisphenol A
- Development, Optimization, and In Vitro/In Vivo Evaluation of Azelaic Acid Transethosomal Gel for Antidermatophyte Activity
- Design of a gelatin microparticle-containing self-microemulsifying formulation for enhanced oral bioavailability of dutasteride
- Methods and Challenges in Purifying Drug‐Loaded Extracellular Vesicles
- Improving the treatment of bacterial infections caused by multidrug-resistant bacteria through drug repositioning
- The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus
- Niosomes as Vesicular Nanocarriers in Cosmetics: Characterisation, Development and Efficacy
- Spanlastic Nano-Vesicles: A Novel Approach to Improve the Dissolution, Bioavailability, and Pharmacokinetic Behavior of Famotidine
- Hair follicle-targeting drug delivery strategies for the management of hair follicle-associated disorders
- Tailoring Risperidone-Loaded Glycethosomal In Situ Gels Using Box–Behnken Design for Treatment of Schizophrenia-Induced Rats via Intranasal Route
- Inflammatory bowel disease: pathogenesis, diagnosis and current therapeutic approach
- Nanocarrier Systems for Transdermal Drug Delivery
- Development and ex-vivo skin permeation studies of finasteride–poly(lactic acid-<i>co</i>-glycolic acid) and minoxidil–chitosan nanoparticulate systems
- Management of Dermatologic Toxicities
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Pimecrolimus interferes the therapeutic efficacy of human mesenchymal stem cells in atopic dermatitis by regulating NFAT-COX2 signaling
- Physicochemical characterization of finasteride:PEG 6000 and finasteride:Kollidon K25 solid dispersions, and finasteride: β-cyclodextrin inclusion complexes
- Docking and Molecular Dynamics Identify Leads against 5 Alpha Reductase 2 for Benign Prostate Hyperplasia Treatment
- Finasteride Enhances the Generation of Human Myeloid-Derived Suppressor Cells by Up-Regulating the COX2/PGE2 Pathway
- Topical Administration of 15‐Deoxy‐<i>Δ</i><sup>12,14</sup>‐Prostaglandin J<sub>2</sub> Using a Nonionic Cream: Effect on UVB‐Induced Skin Oxidative, Inflammatory, and Histopathological Modifications in Mice
- Diphlorethohydroxycarmalol, Isolated from Ishige okamurae, Increases Prostaglandin E<sub>2</sub>through the Expression of Cyclooxygenase-1 and -2 in HaCaT Human Keratinocytes
- Development and Characterization of In Situ Gelling Nasal Cilostazol Spanlastics
- Progress in Lipid and Inorganic Nanocarriers for Enhanced Skin Drug Delivery
- Fabrication of Novel Omeprazole-Based Chitosan Coated Nanoemulgel Formulation for Potential Anti-Microbia; In Vitro and Ex Vivo Characterizations
- Comparison of the acute ultraviolet photoresponse in congenic albino hairless C57BL/6J mice relative to outbred SKH1 hairless mice